Reverse Docking, Molecular Docking, Absorption, Distribution, and Toxicity Prediction of Artemisinin as an Anti-diabetic Candidate

Ruswanto, Ruswanto and Mardianingrum, Richa and Siswandono, Siswandono and Kesuma, Dini (2020) Reverse Docking, Molecular Docking, Absorption, Distribution, and Toxicity Prediction of Artemisinin as an Anti-diabetic Candidate. Molekul, 15 (2). pp. 88-96. ISSN 1907-9761 (print) , 2503-0310 (electronic)

[thumbnail of Dini Kesuma_Reverse Docking, Molecular Docking, Absorption, Distribution, and Toxicity Prediction of Artemisinin as an Anti-diabetic Candidate_2020.pdf]
Preview
PDF
Dini Kesuma_Reverse Docking, Molecular Docking, Absorption, Distribution, and Toxicity Prediction of Artemisinin as an Anti-diabetic Candidate_2020.pdf

Download (465kB) | Preview
Official URL / DOI: https://doi.org/10.20884/1.jm.2020.15.2.579

Abstract

Aldose reductase is an enzyme that catalyzes one of the steps in the sorbitol (polyol) pathway that is responsible for fructose formation from glucose. In diabetes, aldose reductase activity increases as the glucose concentration increases. The purpose of this research was to identify and develop the use of artemisinin as an anti-diabetic candidate through in silico studies, including reverse docking, receptor analysis, molecular docking, drug scan, absorption, and distributions and toxicity prediction of artemisinin. Based on the results, we conclude that artemisinin can be used as an anti-diabetic candidate through inhibition of aldose reductase.

Item Type: Article
Uncontrolled Keywords: aldose reductase, artemisinin, molecular docking, reverse docking
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Pharmacy > Department of Pharmacy
Depositing User: Ester Sri W. 196039
Date Deposited: 27 Jul 2020 08:09
Last Modified: 24 Mar 2021 16:25
URI: http://repository.ubaya.ac.id/id/eprint/37931

Actions (login required)

View Item View Item